Abstract Background Fluoxetine remains the only pharmacological treatment approved for Bulimia Nervosa, and no other drugs have been approved for eating disorders (EDs). The rationale for exploring psilocybin as a treatment for EDs is compelling, both from biological and psychological perspectives. Moreover, its safety profile in healthy individuals appears favorable. This systematic review...
Anomalies of imagination encompass disturbances of the basic experiential structure of fantasies and imagery that can be explored in a semi-structured way with the Examination of Anomalous Fantasy and Imagination (EAFI). We aimed (1) to examine the distribution of anomalies of imagination among different diagnostic groups and a group of healthy controls, and (2) to examine their relation with...
Self-disorders are temporally persisting, experiential anomalies of subjective experiences that index liability to schizophrenia. They impact on the temporal unfolding of concomitant, diagnostic symptoms and can be suitably characterized through the Examination of Anomalous Self Ex periences (EASE). Capitalizing on the results of a recent longitudinal study, we explored the relevant patterns of...